US3892649A - Electrodeposition of bone within a plastic matrix - Google Patents
Electrodeposition of bone within a plastic matrix Download PDFInfo
- Publication number
- US3892649A US3892649A US469181A US46918174A US3892649A US 3892649 A US3892649 A US 3892649A US 469181 A US469181 A US 469181A US 46918174 A US46918174 A US 46918174A US 3892649 A US3892649 A US 3892649A
- Authority
- US
- United States
- Prior art keywords
- bone
- solvent
- polyamic acid
- solution
- organic salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 210000000988 bone and bone Anatomy 0.000 title claims abstract description 77
- 238000004070 electrodeposition Methods 0.000 title claims abstract description 22
- 239000011159 matrix material Substances 0.000 title claims abstract description 17
- 239000004033 plastic Substances 0.000 title claims abstract description 13
- 238000000034 method Methods 0.000 claims abstract description 59
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims abstract description 50
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 claims abstract description 34
- 239000002245 particle Substances 0.000 claims abstract description 31
- 229920005575 poly(amic acid) Polymers 0.000 claims abstract description 31
- 239000002904 solvent Substances 0.000 claims abstract description 27
- 150000003839 salts Chemical class 0.000 claims abstract description 17
- 239000000725 suspension Substances 0.000 claims abstract description 14
- 150000001412 amines Chemical class 0.000 claims abstract description 12
- 238000000151 deposition Methods 0.000 claims abstract description 11
- 239000007943 implant Substances 0.000 claims abstract description 11
- 239000011230 binding agent Substances 0.000 claims abstract description 9
- 230000008021 deposition Effects 0.000 claims abstract description 9
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims abstract description 6
- 230000000399 orthopedic effect Effects 0.000 claims abstract description 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims description 36
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims description 10
- 239000000758 substrate Substances 0.000 claims description 10
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 claims description 10
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 claims description 9
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims description 9
- SECXISVLQFMRJM-UHFFFAOYSA-N N-Methylpyrrolidone Chemical compound CN1CCCC1=O SECXISVLQFMRJM-UHFFFAOYSA-N 0.000 claims description 8
- 125000003118 aryl group Chemical group 0.000 claims description 8
- 230000008439 repair process Effects 0.000 claims description 8
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 claims description 6
- 230000000977 initiatory effect Effects 0.000 claims description 6
- FDPIMTJIUBPUKL-UHFFFAOYSA-N pentan-3-one Chemical compound CCC(=O)CC FDPIMTJIUBPUKL-UHFFFAOYSA-N 0.000 claims description 6
- HTLZVHNRZJPSMI-UHFFFAOYSA-N N-ethylpiperidine Chemical compound CCN1CCCCC1 HTLZVHNRZJPSMI-UHFFFAOYSA-N 0.000 claims description 5
- 230000002708 enhancing effect Effects 0.000 claims description 5
- 229920000642 polymer Polymers 0.000 claims description 5
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims description 5
- 239000002253 acid Substances 0.000 claims description 4
- XXBDWLFCJWSEKW-UHFFFAOYSA-N dimethylbenzylamine Chemical compound CN(C)CC1=CC=CC=C1 XXBDWLFCJWSEKW-UHFFFAOYSA-N 0.000 claims description 4
- XNLICIUVMPYHGG-UHFFFAOYSA-N pentan-2-one Chemical compound CCCC(C)=O XNLICIUVMPYHGG-UHFFFAOYSA-N 0.000 claims description 4
- OZXIZRZFGJZWBF-UHFFFAOYSA-N 1,3,5-trimethyl-2-(2,4,6-trimethylphenoxy)benzene Chemical compound CC1=CC(C)=CC(C)=C1OC1=C(C)C=C(C)C=C1C OZXIZRZFGJZWBF-UHFFFAOYSA-N 0.000 claims description 3
- NTIZESTWPVYFNL-UHFFFAOYSA-N Methyl isobutyl ketone Chemical compound CC(C)CC(C)=O NTIZESTWPVYFNL-UHFFFAOYSA-N 0.000 claims description 3
- UIHCLUNTQKBZGK-UHFFFAOYSA-N Methyl isobutyl ketone Natural products CCC(C)C(C)=O UIHCLUNTQKBZGK-UHFFFAOYSA-N 0.000 claims description 3
- SHOJXDKTYKFBRD-UHFFFAOYSA-N mesityl oxide Natural products CC(C)=CC(C)=O SHOJXDKTYKFBRD-UHFFFAOYSA-N 0.000 claims description 3
- FXHOOIRPVKKKFG-UHFFFAOYSA-N N,N-Dimethylacetamide Chemical compound CN(C)C(C)=O FXHOOIRPVKKKFG-UHFFFAOYSA-N 0.000 claims description 2
- 229940113088 dimethylacetamide Drugs 0.000 claims description 2
- 239000003792 electrolyte Substances 0.000 claims description 2
- MCTWTZJPVLRJOU-UHFFFAOYSA-N 1-methyl-1H-imidazole Chemical compound CN1C=CN=C1 MCTWTZJPVLRJOU-UHFFFAOYSA-N 0.000 claims 3
- 238000000576 coating method Methods 0.000 abstract description 22
- 239000011248 coating agent Substances 0.000 abstract description 12
- 239000004642 Polyimide Substances 0.000 abstract description 4
- 229920001721 polyimide Polymers 0.000 abstract description 4
- 239000000463 material Substances 0.000 abstract description 3
- 239000012046 mixed solvent Substances 0.000 abstract description 3
- 239000000243 solution Substances 0.000 description 17
- 229910000831 Steel Inorganic materials 0.000 description 16
- 239000010959 steel Substances 0.000 description 16
- 230000008569 process Effects 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 230000008901 benefit Effects 0.000 description 2
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 2
- 230000008468 bone growth Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- LXBGSDVWAMZHDD-UHFFFAOYSA-N 2-methyl-1h-imidazole Chemical compound CC1=NC=CN1 LXBGSDVWAMZHDD-UHFFFAOYSA-N 0.000 description 1
- RZVAJINKPMORJF-UHFFFAOYSA-N Acetaminophen Chemical compound CC(=O)NC1=CC=C(O)C=C1 RZVAJINKPMORJF-UHFFFAOYSA-N 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 238000005299 abrasion Methods 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000001246 colloidal dispersion Methods 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 238000005336 cracking Methods 0.000 description 1
- 125000000118 dimethyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 238000013007 heat curing Methods 0.000 description 1
- 238000009863 impact test Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 229910052738 indium Inorganic materials 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- XLSZMDLNRCVEIJ-UHFFFAOYSA-N methylimidazole Natural products CC1=CNC=N1 XLSZMDLNRCVEIJ-UHFFFAOYSA-N 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 239000005297 pyrex Substances 0.000 description 1
- 238000001552 radio frequency sputter deposition Methods 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000010998 test method Methods 0.000 description 1
- 238000003878 thermal aging Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/30—Joints
- A61F2/30767—Special external or bone-contacting surface, e.g. coating for improving bone ingrowth
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/28—Materials for coating prostheses
- A61L27/30—Inorganic materials
- A61L27/32—Phosphorus-containing materials, e.g. apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/46—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with phosphorus-containing inorganic fillers
-
- C—CHEMISTRY; METALLURGY
- C25—ELECTROLYTIC OR ELECTROPHORETIC PROCESSES; APPARATUS THEREFOR
- C25D—PROCESSES FOR THE ELECTROLYTIC OR ELECTROPHORETIC PRODUCTION OF COATINGS; ELECTROFORMING; APPARATUS THEREFOR
- C25D13/00—Electrophoretic coating characterised by the process
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00389—The prosthesis being coated or covered with a particular material
- A61F2310/00592—Coating or prosthesis-covering structure made of ceramics or of ceramic-like compounds
- A61F2310/00796—Coating or prosthesis-covering structure made of a phosphorus-containing compound, e.g. hydroxy(l)apatite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2310/00—Prostheses classified in A61F2/28 or A61F2/30 - A61F2/44 being constructed from or coated with a particular material
- A61F2310/00389—The prosthesis being coated or covered with a particular material
- A61F2310/00958—Coating or prosthesis-covering structure made of bone or of bony tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/02—Materials or treatment for tissue regeneration for reconstruction of bones; weight-bearing implants
Definitions
- ABSTRACT A method of improving orthopedic implant material by the simultaneous electrodeposition of bone particles and an inert plastic binder onto a prosthesis is provided.
- a polyamic acid is dissolved in a solvent such as dimethylsulfoxide and an amine is added to the solution to produce the organic salt of a free carboxyl group.
- a colloidal suspension of the organic salt and fine bone particles in a mixed solvent comprised of acetone and dimethylsulfoxide is placed in a receptacle and a voltage is applied to a pair of electrodes immersed in the solution causing the deposition on the anode of bone in a polyamic acid plastic matrix. After subsequent cure, the result is a coating of bone within a polyimide matrix on the electrode.
- the present invention concerns the improvement of orthopedic implant materials and, more particularly, the anodic formation of bone coatings on prosthesis by electrodeposition of a composite of bone particles within a polyamic acid matrix which on subsequent heat cure results in bone particles within a polyimide plastic matrix.
- Advances in the field of total prosthetic replacement of bones include electrodepositing bone particles on prostheses and, also, coating such prosthesis by the rf sputtering process.
- the objective in such orthopedic implants is to determine a reliable and effective method
- the electrodeposition of some of the polyamic acids and their subsequent conversion to corresponding polyimides has been accomplished in the prior art.
- the teachings and techniques of such processes have not, however, been applied to the electrodeposition of particles of human or animal matter on prosthetic or other substrates. This application is the subject of the present invention.
- a colloidal suspension suitable for electrodeposition is a necessary precedent to at least one process for forming a coating on a prosthesis.
- a colloidal suspension is obtained by dissolving a commercially available polyamic acid such as Dupont Pyre-M.L. in a soland means for enhancing bone growth around the imi5 vent such as dimethylsulfoxide.
- An amine when added Plant and into the POres Ofthe implant Wail Enhancing to this solution produces an organic salt of free carbone growth is particularly important in bone-bridge boxy] groups which are present in the polyamic acid.
- the present invention Provides stronger and more mixed solvent system which is comprised of acetone ily formed implants or prostheses which have bone red di h l lf xide placement characteristics im ar to ivory.
- the Present invention Provides a method trolyte and an electrolytic apparatus comprising a of electrochemically depositing bone Particles and Pyrex glass reaction kettle with cover and two metal r i binder onto the external surface of a bone proselectrodes 2 X l X 0.02 inches, a coating is obtained on thesis to form a coating which stimulates bone attachth di l t d h a lt i li d t th ment.
- the organic binder is preferably O t e p ly mi metal electrodes.
- acid family Such as Dupont y which n 300 ml of solution is used and the anode-to-cathode Cured Provides a Poiyimide of high thermal -h separation is maintained at 1 inch.
- the potential apand is inert to attack from most chemicals. plied between the electrodes is derived from a variable Accordingly, it is an object of the present invention voltage d w r supply and coatings of various thickt provide a method of enhancing bone growth on prosness and hardness are obtained and tested for mechanitheses by binding bone particles to a prosthesis. cal, physical and thermal properties,
- Another object Of this invention s to Provide a Tests conducted on the coatings obtained according method of blending bone particles and a binder to proto h foregoing procedure h h f ll i h mote the formation of a coating of controlled thickness i l, ph ical and thermal properti of elect odeposon a prosthesis.
- Pyre-M.L. Pyre-M.L. is a 16.5% by weight solution
- a further object of this invention is to provide an imf an ti l lli i id i N h l 2 proved method of depositing bone and a plastic matelid lv t,
- the effect of applied voltage on bone/Pyre-M.L. colloidal dispersions is shown in the following table.
- the test specimen consisted of 5 grams of bone contained in 50 ml Pyre-M.L., 10 ml triethylamine, 200 ml dimethylsulfoxide and 1,000 ml acetone.
- the coatings were cured to 300C in an oven for one hour.
- Adhesion 50 60 steel -0. 5 good 5 O 60 steel 1 good 5 O 60 Cr 1 good l 60 Al -2 good 100 60 Cu -2 good
- the effect of electrodeposition time on various coating thickness of bone/Pyre-M.L. is indicated in the folcoating, the bone level appearing to be arbitrarily lim- I ited, to substantially Adhesion is excellent for coatings of 2 mils but deteriorates rapidly as coatingthicknesses of 10 mils are approached.
- the colloidal suspension contained 10 H O O grams of bone contained in 50 ml Pyre-M.L., 10 ml triethylamine, 200 ml dimethylsulfoxide and 1,000 ml ac- C OH etone. The coatings were cured to 300C in an oven for one hour.
- Table IV shows the results of applying various Suitable solvents for the polyamic acids are dimethyl voltages to varying weights of bone over varying depoacetamide, dimethyl formamide, N-methyl-Z sition times. In these tests, an organic matrix composipyrrolidone and dimethylsulfoxide.
- both 01' more, thicker coatings are obtained in all but one inbone particles and organic matrix are formed on the orstance but these coatings have P r 0 very P adhethopedic implant.
- the organic matrix which is evenly sion properties. dispersed within the bone particles, is believed to pro-
- the best coatings for adhesion and thickness are mote healing at least partly because of the spacing of achieved utilizing a solution comprised of an organic the bone particles which makes them accessible to atmatrix of 50 ml Pyre-M.L., l0 t'riethylamine, 200 ml dimethylsulfoxide and 1,000 ml acetone. It appears that the mobility of Pyre-M.L., under the influence of the electric field, far exceeds that of the bone particles.
- electrodeposition of finely divided bone particles from polyamic acid dispersions onto metal substrates provides a basis for the preparation of prostheses for both joint and/or socket replacement, bone bridge, etc. These prostheses enhance bone repair rates by providing a coating to which living bone may adhere and which ultimately is completely replaced by living bone.
- the electrodeposition process provides several advantages in the forming of superior prosthetic devices, one being a controlled thickness of electrodeposition and another being a uniform coverage of irregularly shaped substrates.
- the controlled thickness feature reduces the finishing required to produce a frictionless freely movable joint.
- a further advantage is obtained through the dissolution of the metallic electrode during electrodeposition.
- the process of the invention is also rapid in relation to normal body processes or other forms of bone repair such as pins, clamps, etc.
- the process also is exceedingly economical since all of the compounds used therein are readily available and no complex equipment is required.
- a method of forming a prosthesis for bone repair or replacement comprising:
- polyamic acid is taken from a group of aromatic polyamic acid polymers having the recurring unit:
- n is at least 15.
- polyamic acid is a 16.5% by Weight solution of an aromatic polymellitamic acid in N-methyl-2pyrrolidone solvent.
- amine is taken from the group including triethylamine, trimethylamine, N,N-dimethylbenzylamine, N-ethylpiperidine, pyridine and l-methylimidazole.
- a method of producing in orthopedic implant for enhancing bone repair rates in bone bridge and other bone operations comprising:
- a solvent taken from a group including dimethyl acetamide, dimethyl formamide, N-methyl-Z- pyrrolidone and dimethylsulfoxide
- a nonsolvent taken from the group including methyl isobutyl ketone, methyl ethyl ketone, methyl n-propyl ketone, diethyl ketone, mesityl oxide, cyclo
- said implant is the anodic electrode of an electrolytic deposition system wherein a dc voltage of from 50 to volts is applied across the electrode thereof 9.
- said organic salt is taken from the group triethylamine, trimethylamine, N,N-dimethylbenzylamine, N-ethylpiperidine, pyridine and l-methylimidazole.
- a method of forming a prosthesis for bone repair or replacement comprising:
- the inert plastic binder is an organic matrix formed by a polyamic acid dissolved in a solvent:
- said substrate is the anodic electrode of an electrolytic deposition system in which a dc voltage of from 50 to 100 volts is applied across the electrodes thereof.
- polyamic acid is taken from a group of aromatic polyamic acid polymers having the recurring unit:
- n is at least 15
Abstract
A method of improving orthopedic implant material by the simultaneous electrodeposition of bone particles and an inert plastic binder onto a prosthesis is provided. A polyamic acid is dissolved in a solvent such as dimethylsulfoxide and an amine is added to the solution to produce the organic salt of a free carboxyl group. A colloidal suspension of the organic salt and fine bone particles in a mixed solvent comprised of acetone and dimethylsulfoxide is placed in a receptacle and a voltage is applied to a pair of electrodes immersed in the solution causing the deposition on the anode of bone in a polyamic acid plastic matrix. After subsequent cure, the result is a coating of bone within a polyimide matrix on the electrode.
Description
United States Patent [1 1 Phillips et al.
[451 July 1,1975
[ ELECTRODEPOSITION OF BONE WITHIN A PLASTIC MATRIX [75] Inventors: David C. Phillips, Pittsburgh; Bevil J. Shaw, Murrysville, both of Pa.
[73] Assignee: The United States of America as represented by the Secretary of the Navy, Washington, DC.
[22] Filed: May 13, 1974 [21] Appl. No.: 469,181
[56] References Cited UNITED STATES PATENTS l/l97l Mizuguchi et all 204/181 2/197] Seiderman 204/l8l Primary Examiner-Howard S. Williams Attorney. Agent, or Firm-R. S. Sciascia; C. E. Vautrain, Jr.
[57] ABSTRACT A method of improving orthopedic implant material by the simultaneous electrodeposition of bone particles and an inert plastic binder onto a prosthesis is provided. A polyamic acid is dissolved in a solvent such as dimethylsulfoxide and an amine is added to the solution to produce the organic salt of a free carboxyl group. A colloidal suspension of the organic salt and fine bone particles in a mixed solvent comprised of acetone and dimethylsulfoxide is placed in a receptacle and a voltage is applied to a pair of electrodes immersed in the solution causing the deposition on the anode of bone in a polyamic acid plastic matrix. After subsequent cure, the result is a coating of bone within a polyimide matrix on the electrode.
20 Claims, N0 Drawings ELECTRODEPOSITION OF BONE WITHIN A PLASTIC MATRIX The present invention concerns the improvement of orthopedic implant materials and, more particularly, the anodic formation of bone coatings on prosthesis by electrodeposition of a composite of bone particles within a polyamic acid matrix which on subsequent heat cure results in bone particles within a polyimide plastic matrix. i
Advances in the field of total prosthetic replacement of bones include electrodepositing bone particles on prostheses and, also, coating such prosthesis by the rf sputtering process. The objective in such orthopedic implants is to determine a reliable and effective method The electrodeposition of some of the polyamic acids and their subsequent conversion to corresponding polyimides has been accomplished in the prior art. The teachings and techniques of such processes have not, however, been applied to the electrodeposition of particles of human or animal matter on prosthetic or other substrates. This application is the subject of the present invention. v
The formation of a colloidal suspension suitable for electrodeposition is a necessary precedent to at least one process for forming a coating on a prosthesis. According to the present invention, such a colloidal suspension is obtained by dissolving a commercially available polyamic acid such as Dupont Pyre-M.L. in a soland means for enhancing bone growth around the imi5 vent such as dimethylsulfoxide. An amine when added Plant and into the POres Ofthe implant Wail Enhancing to this solution produces an organic salt of free carbone growth is particularly important in bone-bridge boxy] groups which are present in the polyamic acid. operations where necrosis is inevitable if the bones are Th l i i h d to approximately 40C d not united in reasonable time- Often the bone p in maintained at this temperature for minutes. The for- Such cases is tallied with autogehous h but this 2O mer solution is added to a rapidly stirred non-solvent ally requires a second operation. In certain instances, uch as acetone and ground bone is then added to the the bone p has been Successfully bridged with ivory vigorously stirred solution, resulting in a colloidal suswhich also is itself replaced in time with living bone. pension f th organic lt d b t in d i a The present invention Provides stronger and more mixed solvent system which is comprised of acetone ily formed implants or prostheses which have bone red di h l lf xide placement characteristics im ar to ivory. Using the foregoing colloidal suspension as the elecin general, the Present invention Provides a method trolyte and an electrolytic apparatus comprising a of electrochemically depositing bone Particles and Pyrex glass reaction kettle with cover and two metal r i binder onto the external surface of a bone proselectrodes 2 X l X 0.02 inches, a coating is obtained on thesis to form a coating which stimulates bone attachth di l t d h a lt i li d t th ment. The organic binder is preferably O t e p ly mi metal electrodes. In a preferred embodiment process, acid family Such as Dupont y which n 300 ml of solution is used and the anode-to-cathode Cured Provides a Poiyimide of high thermal -h separation is maintained at 1 inch. The potential apand is inert to attack from most chemicals. plied between the electrodes is derived from a variable Accordingly, it is an object of the present invention voltage d w r supply and coatings of various thickt provide a method of enhancing bone growth on prosness and hardness are obtained and tested for mechanitheses by binding bone particles to a prosthesis. cal, physical and thermal properties,
Another object Of this invention s to Provide a Tests conducted on the coatings obtained according method of blending bone particles and a binder to proto h foregoing procedure h h f ll i h mote the formation of a coating of controlled thickness i l, ph ical and thermal properti of elect odeposon a prosthesis. ited Pyre-M.L. Pyre-M.L. is a 16.5% by weight solution A further object of this invention is to provide an imf an ti l lli i id i N h l 2 proved method of depositing bone and a plastic matelid lv t,
TABLE I Typical Value Property at 25C Test Method Folding endurance* Ultimate elongation Impact test Abrasion resistance Adhesion & flexibility Thermal aging Tensile strength* Coefficient of friction* 30,000 cycles ASTM D-882-64T 80 in-lb (direct Falling Ball and reverse) impact 400g Hoffman scratch test No cracking or loss of adhesion (1/16 Conical mandrel in. bend) Expected life l0.()00 AlEE Method 57 hr at 250C 24,000 psi ASTM D-882 0.42 ASTM D1505 Test evaluated on stripped film. Test evaluated on substrate (Cu and Al).
The effect of applied voltage on bone/Pyre-M.L. colloidal dispersions is shown in the following table. The test specimen consisted of 5 grams of bone contained in 50 ml Pyre-M.L., 10 ml triethylamine, 200 ml dimethylsulfoxide and 1,000 ml acetone. The coatings were cured to 300C in an oven for one hour.
TABL E II Applied Deposition Coating Voltage Time Thickness (volts) (secs) Anode mils Adhesion 50 60 steel -0. 5 good 5 O 60 steel 1 good 5 O 60 Cr 1 good l 60 Al -2 good 100 60 Cu -2 good The effect of electrodeposition time on various coating thickness of bone/Pyre-M.L. is indicated in the folcoating, the bone level appearing to be arbitrarily lim- I ited, to substantially Adhesion is excellent for coatings of 2 mils but deteriorates rapidly as coatingthicknesses of 10 mils are approached.
Other suitable aromatic polyamic acid polymers ca be represented by the recurring unit:
lowing table. The colloidal suspension contained 10 H O O grams of bone contained in 50 ml Pyre-M.L., 10 ml triethylamine, 200 ml dimethylsulfoxide and 1,000 ml ac- C OH etone. The coatings were cured to 300C in an oven for one hour.
TABLE III R .0 Applied Deposition Coating Voltage Time Thickness I (volts) (secs) Anode mils Adhesion HO-|(|I l--' 100 60 steel -l good I I I v 100 100 steel -2 good o O H 100 120 steel 5 good n 100 300 steel 10 very poor v in which n is at least 15.
Table IV below shows the results of applying various Suitable solvents for the polyamic acids are dimethyl voltages to varying weights of bone over varying depoacetamide, dimethyl formamide, N-methyl-Z sition times. In these tests, an organic matrix composipyrrolidone and dimethylsulfoxide. Preferred nontion of 50 ml Pyre-M.L., 10 ml triethylamine, 200 ml solvents, in addition to acetone, for the polyamic acid dimethylsulfoxide and 1,000 ml acetone was used and include methyl isobutyl ketone, methyl ethyl ketone, the coatings were cured at 300C in an oven for one methyl 'n-propyl ketone, diethyl ketone, mesityl oxide h V and cyclohexanone. Suitable bases, for salt-solution,
TABLE IV Approximate Weight of Applied Deposition Coating Bone Voltage Time Thickness I g V secs Anode mils Adhesion v 5 30 60 steel I I 0.5 good i 5 60 steel l good 5 50 60 Cr 1 good 5 100 60 Al 2 good 5 100 60 Cu 2 poor 10 50 120 steel 2 good 10 I00 l20 steel 5 poor 10 100 300 steel 10 very poor 25 50 30 steel 1 poor 25 100 60 steel 4 very poor 25 100 120 steel 6 very poor 25 100 300 steel 10 very poor Four different bone concentrations were investiinclude triethylamine, trimethylamine, N,N-dimethylgated. Under the influence of the electric field, bone benzylamine, N-ethylpiperidine, pyridine and 1- particles were transported within the organic matrix to' methylimidazole. the anode and deposited at this electrode. Concentra- The present invention thus teaches a process by tions of lower weights of bone produced cathode coatwhich bone and organic matrix may be simultaneously h1g5 which have good adhesion to the 511211111655 Steel adhered by electro-chemical deposition onto orthopesubstrate. When the concentration is increased twofold di i l ts, In the electro-deposition process, both 01' more, thicker coatings are obtained in all but one inbone particles and organic matrix are formed on the orstance but these coatings have P r 0 very P adhethopedic implant. The organic matrix, which is evenly sion properties. dispersed within the bone particles, is believed to pro- The best coatings for adhesion and thickness are mote healing at least partly because of the spacing of achieved utilizing a solution comprised of an organic the bone particles which makes them accessible to atmatrix of 50 ml Pyre-M.L., l0 t'riethylamine, 200 ml dimethylsulfoxide and 1,000 ml acetone. It appears that the mobility of Pyre-M.L., under the influence of the electric field, far exceeds that of the bone particles.
tachment of living bone within the matrix. In the preferred embodiment, electrodeposition of finely divided bone particles from polyamic acid dispersions onto metal substrates provides a basis for the preparation of prostheses for both joint and/or socket replacement, bone bridge, etc. These prostheses enhance bone repair rates by providing a coating to which living bone may adhere and which ultimately is completely replaced by living bone.
The electrodeposition process provides several advantages in the forming of superior prosthetic devices, one being a controlled thickness of electrodeposition and another being a uniform coverage of irregularly shaped substrates. The controlled thickness feature reduces the finishing required to produce a frictionless freely movable joint. A further advantage is obtained through the dissolution of the metallic electrode during electrodeposition.
The process of the invention is also rapid in relation to normal body processes or other forms of bone repair such as pins, clamps, etc. The process also is exceedingly economical since all of the compounds used therein are readily available and no complex equipment is required.
Obviously many modifications and variations of the present invention are possible in the light of the above teachings.
What is claimed is:
1. A method of forming a prosthesis for bone repair or replacement comprising:
electrodepositing finely divided powdered bone particles from colloidal suspensions of said bone particles in a solution comprising acetone, dimethylsulfoxide, an organic amine and a polyamic acid onto a metallic substrate in the form of said prosthesis.
2. The method of claim 1 wherein the polyamic acid is taken from a group of aromatic polyamic acid polymers having the recurring unit:
in which n is at least 15.
3. The method of claim 2 wherein the polyamic acid is a 16.5% by Weight solution of an aromatic polymellitamic acid in N-methyl-2pyrrolidone solvent.
4. The method of claim 3 wherein said amine is taken from the group including triethylamine, trimethylamine, N,N-dimethylbenzylamine, N-ethylpiperidine, pyridine and l-methylimidazole.
5. The method of claim 4 wherein said solution is characterized by the presence of an organic salt of free carboxyl groups,
said solution heated to substantially 40C and maintained at said temperature for substantially minutes prior to initiating said electrodeposition.
6. A method of producing in orthopedic implant for enhancing bone repair rates in bone bridge and other bone operations comprising:
dispensing ground bone particles in a solution containing a polyamic acid and an organic salt in a solvent taken from a group including dimethyl acetamide, dimethyl formamide, N-methyl-Z- pyrrolidone and dimethylsulfoxide, and a nonsolvent taken from the group including methyl isobutyl ketone, methyl ethyl ketone, methyl n-propyl ketone, diethyl ketone, mesityl oxide, cyclohexanone and acetone so as to obtain a colloidal suspension of an organic salt and bone.
7. The method of claim 6 wherein said solvent is dimethylsulfoxide, said non-solvent is acetone and said solution is heated to substantially 40C and maintained at said temperature for substantially 15 minutes before initiating said electrodeposition.
8. The method of claim 7 wherein said implant is the anodic electrode of an electrolytic deposition system wherein a dc voltage of from 50 to volts is applied across the electrode thereof 9. The method of claim 8 wherein said organic salt is taken from the group triethylamine, trimethylamine, N,N-dimethylbenzylamine, N-ethylpiperidine, pyridine and l-methylimidazole.
10. A method of forming a prosthesis for bone repair or replacement comprising:
electrodepositing finely divided powdered bone particles from a colloidal suspension of said bone particles in an inert plastic binder onto a metallic substrate in the form of said prosthesis.
11. The method of claim 10 wherein the inert plastic binder is an organic matrix formed by a polyamic acid dissolved in a solvent:
an amine added to the solution to produce the organic salt of a free carboxyl group; and
said solution and said bone particles stirred into a non-solvent electrolyte so as to form a colloidal suspension of said organic salt and said bone particles in said solvent and non-solvent.
12. The method of claim 11 wherein said solution is heated to substantially 40C and maintained at said temperature for substantially 15 minutes prior to initiating said electrodeposition.
13. The method of claim 12 wherein said substrate is the anodic electrode of an electrolytic deposition system in which a dc voltage of from 50 to 100 volts is applied across the electrodes thereof.
14. The method of claim 13 wherein the polyamic acid is taken from a group of aromatic polyamic acid polymers having the recurring unit:
in which n is at least 15;
16. The method of claim 15 wherein the solvent is dimethylsulfoxide.
17. The method of claim 16 wherein the non-solvent is acetone.
18. The method of claim 17 wherein the amine is lmethylimidazole.
19; The method of claim 17 wherein the amine is triethylamine.
20. The method of claim 19 wherein the portions of the components are 5 grams bone, 50 ml polyamic acid, 10 ml triethylamine, 200 ml dimethylsulfoxide
Claims (20)
1. A METHOD OF FORMING A PROSTHESIS FOR BONE REPAIR OR REPLACEMENT COMPRISING: ELECTRODEPOSITING FINELY DIVIDED POWDERED BONE PARTICLES FROM COLLOIDAL SUSPENSIONS OF SAID BONE PARTICLES IN A SOLUTION COMPRISING ACETONE, DIMETHYLSUFLOXIDE, AN ORGANIC AMINE AND A POLYAMIC ACID ONTO A METALLIC SUBSTRATE IN THE FORM OF SAID PROSTHESIS.
2. The method of claim 1 wherein the polyamic acid is taken from a group of aromatic polyamic acid polymers having the recurring unit:
3. The method of claim 2 wherein the polyamic acid is a 16.5% by weight solution of an aromatic polymellitamic acid in N-methyl-2-pyrrolidone solvent.
4. The method of claim 3 wherein said amine is taken from the group including triethylamine, trimethylamine, N,N-dimethylbenzylamine, N-ethylpiperidine, pyridine and 1-methylimidazole.
5. The method of claim 4 wherein said solution is characterized by the presence of an organic salt of free carboxyl groups, said solution heated to substantially 40*C and maintained at said temperature for substantially 15 minutes prior to initiating said electrodeposition.
6. A method of producing in orthopedic implant for enhancing bone repair rates in bone bridge and other bone operations comprising: dispensing ground bone particles in a solution containing a polyamic acid and an organic salt in a solvent taken from a group including dimethyl acetamide, dimethyl formamide, N-methyl-2-pyrrolidone and dimethylsulfoxide, and a non-solvent taken from the group including methyl isobutyl ketone, methyl ethyl ketone, methyl n-propyl ketone, diethyl ketone, mesityl oxide, cyclohexanone and acetone so as to obtain a colloidal suspension of an organic salt and bone.
7. The method of claim 6 wherein said solvent is dimethylsulfoxide, said non-solvent is acetone and said solution is heated to substantially 40*C and maintained at said temperature for substantially 15 minutes before initiating said electrodeposition.
8. The method of claim 7 wherein said implant is the anodic electrode of an electrolytic deposition system wherein a dc voltage of from 50 to 100 volts is applied across the electrode thereof.
9. The method of claim 8 wherein said organic salt is taken from the group triethylamine, trimethylamine, N,N-dimethylbenzylamine, N-ethylpiperidine, pyridine and 1-methylimidazole.
10. A method of forming a prosthesis for bone repair or replacement comprising: electrodepositing finely divided powdered bone particles from a colloidal suspension of said bone particles in an inert plastic binder onto a metallic substrate in the form of said prosthesis.
11. The method of claim 10 wherein the inert plastic binder is an organic matrix formed by a polyamic acid dissolved in a solvent: an amIne added to the solution to produce the organic salt of a free carboxyl group; and said solution and said bone particles stirred into a non-solvent electrolyte so as to form a colloidal suspension of said organic salt and said bone particles in said solvent and non-solvent.
12. The method of claim 11 wherein said solution is heated to substantially 40*C and maintained at said temperature for substantially 15 minutes prior to initiating said electrodeposition.
13. The method of claim 12 wherein said substrate is the anodic electrode of an electrolytic deposition system in which a dc voltage of from 50 to 100 volts is applied across the electrodes thereof.
14. The method of claim 13 wherein the polyamic acid is taken from a group of aromatic polyamic acid polymers having the recurring unit:
15. The method of claim 14 wherein the polyamic acid is a 16.5% by weight solution of an aromatic polymellitamic acid in N-methyl-2-pyrrolidone solvent.
16. The method of claim 15 wherein the solvent is dimethylsulfoxide.
17. The method of claim 16 wherein the non-solvent is acetone.
18. The method of claim 17 wherein the amine is 1-methylimidazole.
19. The method of claim 17 wherein the amine is triethylamine.
20. The method of claim 19 wherein the portions of the components are 5 grams bone, 50 ml polyamic acid, 10 ml triethylamine, 200 ml dimethylsulfoxide and 1,000 ml acetone.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US469181A US3892649A (en) | 1974-05-13 | 1974-05-13 | Electrodeposition of bone within a plastic matrix |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US469181A US3892649A (en) | 1974-05-13 | 1974-05-13 | Electrodeposition of bone within a plastic matrix |
Publications (1)
Publication Number | Publication Date |
---|---|
US3892649A true US3892649A (en) | 1975-07-01 |
Family
ID=23862769
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US469181A Expired - Lifetime US3892649A (en) | 1974-05-13 | 1974-05-13 | Electrodeposition of bone within a plastic matrix |
Country Status (1)
Country | Link |
---|---|
US (1) | US3892649A (en) |
Cited By (19)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2387028A1 (en) * | 1977-04-14 | 1978-11-10 | Union Carbide Corp | COMPOSITE PROSTHESIS INCLUDING AT LEAST ONE PLASTIC MATERIAL AND ITS PROCESS FOR REALIZATION |
EP0011809A1 (en) * | 1978-11-22 | 1980-06-11 | Battelle-Institut e.V. | Intermediate layer for securing a prosthesis |
FR2460129A1 (en) * | 1979-06-29 | 1981-01-23 | Union Carbide Corp | PROTHETIC DEVICE AND METHOD FOR PREPARING THE SAME |
US4338926A (en) * | 1980-11-21 | 1982-07-13 | Howmedica, Inc. | Bone fracture prosthesis with controlled stiffness |
US4491987A (en) * | 1979-09-24 | 1985-01-08 | Clemson University | Method of orthopedic implantation and implant product |
DE3527136A1 (en) * | 1984-08-31 | 1986-03-13 | Bristol-Myers Co., New York, N.Y. | IMPLANT AND METHOD FOR PRODUCING THE SAME |
US5258044A (en) * | 1992-01-30 | 1993-11-02 | Etex Corporation | Electrophoretic deposition of calcium phosphate material on implants |
US6296645B1 (en) | 1999-04-09 | 2001-10-02 | Depuy Orthopaedics, Inc. | Intramedullary nail with non-metal spacers |
US20040146543A1 (en) * | 2002-08-12 | 2004-07-29 | Shimp Lawrence A. | Synthesis of a bone-polymer composite material |
US6783529B2 (en) | 1999-04-09 | 2004-08-31 | Depuy Orthopaedics, Inc. | Non-metal inserts for bone support assembly |
US20050008620A1 (en) * | 2002-10-08 | 2005-01-13 | Shimp Lawrence A. | Coupling agents for orthopedic biomaterials |
US20050008672A1 (en) * | 2002-12-12 | 2005-01-13 | John Winterbottom | Formable and settable polymer bone composite and method of production thereof |
WO2005044325A1 (en) * | 2003-11-05 | 2005-05-19 | Technische Universität Berlin | Composite material containing hydrogen, produced by the electrically-triggered precipitation of a solid phase |
US20050187550A1 (en) * | 2003-12-01 | 2005-08-25 | Grusin N. K. | Humeral nail |
US20050209696A1 (en) * | 2004-01-16 | 2005-09-22 | Jo-Wen Lin | Implant frames for use with settable materials and related methods of use |
US20060200141A1 (en) * | 2005-02-18 | 2006-09-07 | Si Janna | Hindfoot nail |
US20070191963A1 (en) * | 2002-12-12 | 2007-08-16 | John Winterbottom | Injectable and moldable bone substitute materials |
US20080069852A1 (en) * | 2006-01-19 | 2008-03-20 | Shimp Lawrence A | Porous osteoimplant |
US10610270B2 (en) | 2018-01-15 | 2020-04-07 | Glw, Inc. | Hybrid intramedullary rods |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3556969A (en) * | 1967-06-15 | 1971-01-19 | Chukichi Kinoshita | Method and apparatus for obtaining electrodeposited shaped articles from fibrous protein fibrils |
US3563228A (en) * | 1969-02-28 | 1971-02-16 | Maurice Seiderman | Process of forming adherent films on animal tissue |
-
1974
- 1974-05-13 US US469181A patent/US3892649A/en not_active Expired - Lifetime
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3556969A (en) * | 1967-06-15 | 1971-01-19 | Chukichi Kinoshita | Method and apparatus for obtaining electrodeposited shaped articles from fibrous protein fibrils |
US3563228A (en) * | 1969-02-28 | 1971-02-16 | Maurice Seiderman | Process of forming adherent films on animal tissue |
Cited By (43)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2387028A1 (en) * | 1977-04-14 | 1978-11-10 | Union Carbide Corp | COMPOSITE PROSTHESIS INCLUDING AT LEAST ONE PLASTIC MATERIAL AND ITS PROCESS FOR REALIZATION |
EP0011809A1 (en) * | 1978-11-22 | 1980-06-11 | Battelle-Institut e.V. | Intermediate layer for securing a prosthesis |
FR2460129A1 (en) * | 1979-06-29 | 1981-01-23 | Union Carbide Corp | PROTHETIC DEVICE AND METHOD FOR PREPARING THE SAME |
US4491987A (en) * | 1979-09-24 | 1985-01-08 | Clemson University | Method of orthopedic implantation and implant product |
US4338926A (en) * | 1980-11-21 | 1982-07-13 | Howmedica, Inc. | Bone fracture prosthesis with controlled stiffness |
DE3527136A1 (en) * | 1984-08-31 | 1986-03-13 | Bristol-Myers Co., New York, N.Y. | IMPLANT AND METHOD FOR PRODUCING THE SAME |
DE3527136C2 (en) * | 1984-08-31 | 1989-04-13 | Bristol-Myers Co., New York, N.Y., Us | |
US5258044A (en) * | 1992-01-30 | 1993-11-02 | Etex Corporation | Electrophoretic deposition of calcium phosphate material on implants |
US6783529B2 (en) | 1999-04-09 | 2004-08-31 | Depuy Orthopaedics, Inc. | Non-metal inserts for bone support assembly |
US6296645B1 (en) | 1999-04-09 | 2001-10-02 | Depuy Orthopaedics, Inc. | Intramedullary nail with non-metal spacers |
US6709436B1 (en) | 1999-04-09 | 2004-03-23 | Depuy Orthopaedics, Inc. | Non-metal spacers for intramedullary nail |
US6786908B2 (en) | 1999-04-09 | 2004-09-07 | Depuy Orthopaedics, Inc. | Bone fracture support implant with non-metal spacers |
EP2392359A3 (en) * | 2002-08-12 | 2012-03-07 | Warsaw Orthopedic, Inc. | Synthesis of a bone-polymer composite material |
WO2004014452A3 (en) * | 2002-08-12 | 2004-08-26 | Osteotech Inc | Synthesis of a bone-polymer composite material |
US20040146543A1 (en) * | 2002-08-12 | 2004-07-29 | Shimp Lawrence A. | Synthesis of a bone-polymer composite material |
US8771719B2 (en) | 2002-08-12 | 2014-07-08 | Warsaw Orthopedic, Inc. | Synthesis of a bone-polymer composite material |
US7270813B2 (en) | 2002-10-08 | 2007-09-18 | Osteotech, Inc. | Coupling agents for orthopedic biomaterials |
US20050008620A1 (en) * | 2002-10-08 | 2005-01-13 | Shimp Lawrence A. | Coupling agents for orthopedic biomaterials |
US8686064B2 (en) | 2002-10-08 | 2014-04-01 | Warsaw Orthopedic, Inc. | Coupling agents for orthopedic biomaterials |
US10080661B2 (en) | 2002-12-12 | 2018-09-25 | Warsaw Orthopedic, Inc. | Injectable and moldable bone substitute materials |
US20070191963A1 (en) * | 2002-12-12 | 2007-08-16 | John Winterbottom | Injectable and moldable bone substitute materials |
US9308292B2 (en) | 2002-12-12 | 2016-04-12 | Warsaw Orthopedic, Inc. | Formable and settable polymer bone composite and methods of production thereof |
US7291345B2 (en) | 2002-12-12 | 2007-11-06 | Osteotech, Inc. | Formable and settable polymer bone composite and method of production thereof |
US20080063684A1 (en) * | 2002-12-12 | 2008-03-13 | John Winterbottom | Formable and Settable Polymer Bone Composite and Methods of Production Thereof |
US9107751B2 (en) | 2002-12-12 | 2015-08-18 | Warsaw Orthopedic, Inc. | Injectable and moldable bone substitute materials |
US9333080B2 (en) | 2002-12-12 | 2016-05-10 | Warsaw Orthopedic, Inc. | Injectable and moldable bone substitute materials |
US20050008672A1 (en) * | 2002-12-12 | 2005-01-13 | John Winterbottom | Formable and settable polymer bone composite and method of production thereof |
US20070282439A1 (en) * | 2003-11-05 | 2007-12-06 | Technische Universität Berlin | Method of Producing a Composite Material, A Composite Material so Produced and Its Application |
WO2005044325A1 (en) * | 2003-11-05 | 2005-05-19 | Technische Universität Berlin | Composite material containing hydrogen, produced by the electrically-triggered precipitation of a solid phase |
US7947077B2 (en) | 2003-11-05 | 2011-05-24 | Dritte Patentportfolio Beteiligungsgesellschaft Mbh & Co. Kg | Method of producing a composite material, a composite material so produced and its application |
US7655009B2 (en) | 2003-12-01 | 2010-02-02 | Smith & Nephew, Inc. | Humeral nail |
US20050187550A1 (en) * | 2003-12-01 | 2005-08-25 | Grusin N. K. | Humeral nail |
US8012210B2 (en) | 2004-01-16 | 2011-09-06 | Warsaw Orthopedic, Inc. | Implant frames for use with settable materials and related methods of use |
US20050209696A1 (en) * | 2004-01-16 | 2005-09-22 | Jo-Wen Lin | Implant frames for use with settable materials and related methods of use |
USRE44501E1 (en) | 2005-02-18 | 2013-09-17 | Smith & Nephew, Inc. | Hindfoot nail |
US7410488B2 (en) | 2005-02-18 | 2008-08-12 | Smith & Nephew, Inc. | Hindfoot nail |
US20060200141A1 (en) * | 2005-02-18 | 2006-09-07 | Si Janna | Hindfoot nail |
USRE46008E1 (en) | 2005-02-18 | 2016-05-24 | Smith & Nephew, Inc. | Hindfoot nail |
USRE46078E1 (en) | 2005-02-18 | 2016-07-26 | Smith & Nephew, Inc. | Hindfoot nail |
US9034356B2 (en) | 2006-01-19 | 2015-05-19 | Warsaw Orthopedic, Inc. | Porous osteoimplant |
US20080069852A1 (en) * | 2006-01-19 | 2008-03-20 | Shimp Lawrence A | Porous osteoimplant |
US10610270B2 (en) | 2018-01-15 | 2020-04-07 | Glw, Inc. | Hybrid intramedullary rods |
US11826083B2 (en) | 2018-01-15 | 2023-11-28 | Glw, Inc. | Hybrid intramedullary rods |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US3892649A (en) | Electrodeposition of bone within a plastic matrix | |
US3892648A (en) | Electrochemical deposition of bone | |
DE4431862C2 (en) | Process for coating metal and ceramic surfaces with hydroxyapatite | |
CN1068621C (en) | Polyimide compositions for electrodeposition and coatings formed of the same | |
EP0224906B1 (en) | Electrodeposition coating method | |
CN108137955B (en) | Metal-binding, hydrophobic and electrically conductive coating, in particular for fuel cell bipolar plate coatings | |
KR910000077B1 (en) | Poly (arylene sulfide) printed circuit boards | |
US4877512A (en) | Silver/silver chloride compositions | |
Mata et al. | Smart electroconductive bioactive ceramics to promote in situ electrostimulation of bone | |
CH499567A (en) | Polyamide acids in aqs soln from a dianhydride a | |
CN108140855B (en) | Method for depositing metal-binding, hydrophobic and electrically conductive coatings | |
EP0237114B1 (en) | Process for making an electrically conductive adhesive connection | |
DE2427030C3 (en) | Process for the pretreatment of a carrier surface to be electrolessly metallized and the use of the pretreated product | |
DE3038382A1 (en) | REVERSE COATING PROCESS | |
US5104507A (en) | Anodic-cathodic coating for fasteners | |
GB2113233A (en) | A method of preparing electrophorettable polymer emulsions | |
US5051208A (en) | Silver/silver chloride compositions | |
CA2187230C (en) | Crosslinked unsaturated polyesters as flatting agents in aqueous electrocoating compositions | |
DE1646157A1 (en) | Interpolymers of alpha-olefins | |
JPS5949274A (en) | Dispersion of polymer particle in aqueous medium | |
JPH0588871B2 (en) | ||
Delides et al. | Dielectric and thermally stimulated discharge current studies of rubber-modified epoxy resins | |
Pantović Pavlović et al. | Novel in-situ synthesis of hydroxyapatite/titanium oxide composite coatings on titanium by simultaneous anodization/anaphoretic electrodeposition | |
Heo et al. | Cell fouling resistance of PEG-grafted polyimide film for neural implant applications | |
Haspel | Developing a dual-layer system for the mitigation of tin whiskers |